Pluristem to Test Its Radiation-poisoning Treatment in Japan

PLX-R18 could be used to protect those decommissioning Fukushima reactors.

comments Print
The Israeli biotechnology firm Pluristem Therapeutics has partnered with Japan’s Fukushima Medical University to test its radiation treatment derived from human placenta cells, which it hopes will protect...